Aclaris Therapeutics Stock Forecast

Buy or Hold candidate since Jun 22, 2026 Gain 14.88%

The Aclaris Therapeutics stock price gained 4.12% on the last trading day (Thursday, 2nd Jul 2026), rising from $5.34 to $5.56. It has now gained 6 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 4.79% from a day low at $5.33 to a day high of $5.58. The price has risen in 9 of the last 10 days and is up by 25.79% over the past 2 weeks. Volume fell on the last day by -483 thousand shares and in total, 2 million shares were bought and sold for approximately $10.61 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock has broken the very wide and strong rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $5.55, a level that may pose a second chance to hit a runner. According to fan-theory $6.80 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

ACRS Signals & Forecast

The Aclaris Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $5.13 and $4.64. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 35.61%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Aclaris Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $5.00 and $4.50. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Aclaris Therapeutics finds support just below today's level at $5.00. If this is broken, then the next support from accumulated volume will be at $4.50 and $4.34.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.255 between high and low, or 4.79%. For the last week, the stock has had daily average volatility of 6.49%.

The Aclaris Therapeutics stock is extremely overbought on RSI14 (87). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken. Since the Aclaris Therapeutics has been rising for 6 days in a row, the risk over the next couple of days has increased. As we cannot be certain with regards to the size of the reaction, we urge caution.

Our recommended stop-loss: $5.41 (-2.76%) (This stock has high daily movements and this gives high risk. The RSI14 is 87 and this increases the risk substantially. There is a buy signal from a pivot bottom found 15 days ago.)

Trading Expectations (ACRS) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Aclaris Therapeutics to open at $5.49, and during the day (based on 14 day Average True Range), to move between $5.42 and $5.70, which gives a possible trading interval of +/-$0.282 (+/-5.21%) up or down from last closing price. If Aclaris Therapeutics takes out the full calculated possible swing range there will be an estimated 5.21% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $5.00, some $0.560 (10.07%) from the current price of $5.56, our system finds the risk reward attractive.

Is Aclaris Therapeutics stock A Buy?

Aclaris Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on July 6, 2026 - $5.49 ( 1.29%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk